Icon to close the modal
Support
Sales
Phone Icon
1.844.8.BD.LIFE (1.844.823.5433)
Modal Close Icon
Sales Form
Please fill out the form and a sales representative will get in touch with you.

Capability:

Product Line:

Icon to close thank you modal
Thank you for contacting our sales team!
A sales representive will get in touch with you shortly.
Ordering
Phone Icon
1.714.283.2228
5 a.m. to 4 p.m. PT
Fax Icon
1.714.283.8424
oem@carefusion.com
Customer Service
Phone Icon
1.844.8.BD.LIFE (1.844.823.5433)
Fax Icon
1.800.847.2220

BD Nexiva™ Closed IV Catheter System

Preserving sites and protecting veins

Contact Us navigation arrow
Carousel Image
Carousel Image
Carousel Image
Carousel Image
Loading
tabs dropdown arrow
Overview

The BD Nexiva™ IV catheter, shown to preserve sites for longer and designed to protect patients by reducing the risk of complications and restarts.1,2*

BD IV technologies can help provide significantly better care and experience for your patients, efficiently and cost effectively.1

true
Features and Benefits
BD Vialon™ biomaterial
BD Vialon™ biomaterial

Proprietary BD Vialon™ biomaterial softens up to 70% in the vein, enabling longer dwell times 3† and reducing the chance of mechanical phlebitis by up to 50%. 3†

BD Instaflash™ needle technology
BD Instaflash™ needle technology
Provides quick blood visualization that may help improve insertion success and therefore reduce insertion attempts.
Built-in stabilization platform‡
Built-in stabilization platform‡
Reduces dislodgement by 84% 2§ and complies with the Infusion Therapy Standards of Practice and CDC guidelines for catheter stabilization. 4,5
Pre-attached extension set
Pre-attached extension set
Shown to significantly reduce blood exposure during insertion compared to an open system 2* and aligns with INS guidelines. 4
Reduces manipulations
Integrated extension tubing and stabilization platform‡ is designed to reduce manipulation and movement at the site and has been shown to reduce dislodgement2§ and phlebitisby up to 50%.1,2
Reduces accidental dislodgement
Clinically demonstrated to reduce accidental dislodgement2§ and complies with the Infusion Therapy Standards of Practice4 and CDC guidelines5 for catheter stabilization.
Lessens blood exposure

98% reduced blood exposure during insertion due to the BD Nexiva™ IV catheter preassembled systems.2*

Lowers chance of mechanical phlebitis
Proprietary BD Vialon™ biomaterial softens up to 70% in the vein, enabling longer dwell times3† and reducing the chance of mechanical phlebitis by up to 50%.3†
BD Nexiva™ IV catheter dwells longer

In a randomized study comparing the BD Nexiva™ IV catheter to an open catheter system, the median dwell time for BD Nexiva IV catheters was 144.5 hours and 96 hours for the open system.1

BD Nexiva™ IV catheter preserves sites
By preserving sites for longer, the BD Nexiva IV catheter helps patients get the medication they need as scheduled, potentially decreasing their length of stay.1,2
May help reduce cost and delays in treatment

In a 2014 clinical study, the longer dwell time (6 days)|| of the BD Nexiva™ IV catheter led to cost reductions of approximately $1 million per year per 1000 beds compared with an open system.1**

Videos

Products & Accessories
  • product-image

    Nexiva Dual Port with Q-Syte, 18G x 1.75"

  • product-image

    Nexiva Dual Port with Q-Syte, 20G x 1.75"

  • product-image

    Nexiva Dual Port with Q-Syte, 20G x 1.25"

  • product-image

    Nexiva Dual Port with Q-Syte, 22G x 1.0"

  • product-image

    Nexiva Dual Port with Q-Syte, 24G x 0.75"

  • product-image

    Nexiva Dual Port with Q-Syte, 24G x 0.56"

  • product-image

    Nexiva Single Port, 18G x 1.75"

  • product-image

    Nexiva Single Port, 20G x 1.75"

  • product-image

    Nexiva Single Port, 20G x 1.25"

  • product-image

    Nexiva Single Port, 20G x 1.0"

  • product-image

    Nexiva Single Port, 22G x 1.75"

  • product-image

    Nexiva Single Port, 22G x 1.0"

  • product-image

    Nexiva Single Port, 24G x 0.75"

  • product-image

    Nexiva Single Port, 24G x 0.56"

  • product-image

    Nexiva Dual Port with Q-Syte, 18G x 1.25"

  • product-image

    Nexiva Dual Port with Q-Syte, 20G x 1.0"

  • product-image

    Nexiva Single Port, 18G x 1.25"

References
false

 Best Practices

Centers for Disease Control and Prevention

Catheter stabilization is recognized as an intervention to decrease the risk for phlebitis, catheter migration and dislodgement and may be advantageous in preventing catheter-related bloodstream infections (CRBSIs).3

Infusion Therapy Standards of Practice

Recommend limiting the use of add-on devices to reduce the potential for contamination, additional manipulation, and disconnection.5

Increased clinician safety

98% reduced blood exposure during insertion due to the BD Nexiva IV catheter preassembled system.2*

Increased catheter stabilization

Clinically demonstrated to reduce accidental dislodgement,2‡ meeting Infusion Nursing Society standards4 and CDC guidelines5 for catheter stabilization.

Reduced rate of complications

In a clinical study, results demonstrated a significant reduction in the rate of phlebitis (grade 2 or higher), PIVC-related complications, and infiltration in the closed system versus the open system group.1

Preserves sites

In compliance with industry best practices, BD Nexiva IV catheter is the only all-in-one PIVC system shown to dwell longer and preserve sites vs open system PIVCs.1,2||

Resources
References
false
Reference
Notes

*Compared to an open system.

**Results and savings may vary for other institutions.

†Compared with an FEP catheter.

‡When used with a specially designed 3M™ Tegaderm™ IV site securement dressing.

§Compared with B. Braun Introcan Safety ® catheter with Bard Statlock ® IV Ultra stabilizatio device.

||Compared with 96 hours in an open system.

¶Compared with a non-blood control catheter.

References
  1. González López J, Arribi Vilela A, Fernández Del Palacio E, et al. Indwell times, complications and costs of open vs closed safety peripheral intravenous catheters: a randomized study. J Hosp Infect. 2014;86(2):117-126.
  2. Bausone-Gazda D, Lefaiver CA, Walters SA. A randomized controlled trial to compare the complications of 2 peripheral intravenous catheter stabilization systems. J Infus Nurs. 2010;33(6):371-384.
  3. Maki DG, Ringer M. Risk factors for infusion-related phlebitis with small peripheral venous catheters. Ann Intern Med. 1991;114(10):845-854.
  4. Infusion Nurses Society. Infusion therapy standards of practice. J Infus Nurs. 2016:39(1S).
  5. O’Grady NP, Alexander M, Burns LA, et al. Guidelines for the prevention of intravascular catheter-related infections. CDC. 2011:16.
Chat with us
Our live chat is available between the hours of 8.30am - 5.00pm EST, Monday - Friday
×